Specifications

• Conjugation:
  Unconjugated
• Protein/peptide type:
  Recombinant
• Source:
  HEK293 cells
• Species:
  Human
• Storage conditions:
  –20 °C
• Endotoxin content:
  Less than 1,0 EU per μg by the LAL method.
• Biological activity:
  Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation. Measured by its binding ability in a functional ELISA. Immobilised Natalizumab at 1 μg/ml (100 μl/well) can bind Human ITGA4 and ITGB7 Heterodimer Protein, His Tag and Tag Free (Cat. No. ACRBIT7-H52W4) with a linear range of 4 - 63 ng/ml (QC tested).
• Gene ID:
  P13612-1 (ITGA4) and P26010-1 (ITGB7)
• Carrier-free:
  Y
• Protease-free:
  Y
• Animal-free:
  Y
• Protein synonyms:
  ITGA4&ITGB7|Integrin alpha 4 beta 7
• Protein/peptide name:
  Integrin alpha 4 beta 7
• Purity:
  >90%
• Molecular weight:
  111,4 kDa (ITGA4) and 81,8 kDa (ITGB7)
• Endotoxin level:
  Low
• Formulation:
  Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
• Nuclease-free:
  Y
• Shipping temperature:
  Powder,RT